<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Biol Inorg Chem</journal-id>
      <journal-title>Journal of Biological Inorganic Chemistry</journal-title>
      <issn pub-type="ppub">0949-8257</issn>
      <issn pub-type="epub">1432-1327</issn>
      <publisher>
        <publisher-name>Springer-Verlag</publisher-name>
        <publisher-loc>Berlin/Heidelberg</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">18270754</article-id>
      <article-id pub-id-type="pmc">2359831</article-id>
      <article-id pub-id-type="publisher-id">346</article-id>
      <article-id pub-id-type="doi">10.1007/s00775-008-0346-y</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Paper</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>DNA cleavage and binding selectivity of a heterodinuclear Pt&#x2013;Cu(3-Clip-Phen) complex</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>de Hoog</surname>
            <given-names>Paul</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Piti&#xE9;</surname>
            <given-names>Marguerite</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Amadei</surname>
            <given-names>Giulio</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gamez</surname>
            <given-names>Patrick</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Meunier</surname>
            <given-names>Bernard</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kiss</surname>
            <given-names>Robert</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Reedijk</surname>
            <given-names>Jan</given-names>
          </name>
          <address>
            <phone>+31-71-5274459</phone>
            <fax>+31-71-5274671</fax>
            <email>reedijk@chem.leidenuniv.nl</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Leiden Institute of Chemistry, Gorlaeus Laboratories, Leiden University, P.O. Box 9502, 2300 RA Leiden, The Netherlands </aff>
        <aff id="Aff2"><label>2</label>Laboratoire de Chimie de Coordination du CNRS, 205 route de Narbonne, 31077 Toulouse Cedex 4, France </aff>
        <aff id="Aff3"><label>3</label>Laboratoire de Toxicologie, Institut de Pharmacie, Universit&#xE9; Libre de Bruxelles (ULB), Boulevard du Triomphe, 1050 Bruxelles, Belgium </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>13</day>
        <month>2</month>
        <year>2008</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>5</month>
        <year>2008</year>
      </pub-date>
      <volume>13</volume>
      <issue>4</issue>
      <fpage>575</fpage>
      <lpage>586</lpage>
      <history>
        <date date-type="received">
          <day>15</day>
          <month>11</month>
          <year>2007</year>
        </date>
        <date date-type="accepted">
          <day>21</day>
          <month>1</month>
          <year>2008</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2008</copyright-statement>
      </permissions>
      <abstract>
        <p>The synthesis and nuclease activity of a new bifunctional heterodinuclear platinum&#x2013;copper complex are reported. The design of this ditopic coordination compound is based on the specific mode of action of each component, namely, cisplatin and Cu(3-Clip-Phen), where 3-Clip-Phen is 1-(1,10-phenanthrolin-3-yloxy)-3-(1,10-phenanthrolin-8-yloxy)propan-2-amine. Cisplatin is not only able to direct the Cu(3-Clip-Phen) part to the GG or AG site, but also acts as a kinetically inert DNA anchor. The nuclease activity of this complex has been investigated on supercoiled DNA. The dinuclear compound is not only more active than Cu(3-Clip-Phen), but is also capable of inducing direct double-strand breaks. The sequence selectivity of the mononuclear platinum complex has been investigated by primer extension experiments, which reveal that its interaction with DNA occurs at the same sites as for cisplatin. The <italic>Taq</italic> polymerase recognizes the resulting DNA damage as different from that for unmodified cisplatin. The sequence-selective cleavage has been investigated by high-resolution gel electrophoresis on a 36-bp DNA fragment. Sequence-selective cleavages are observed in the close proximity of the platinum sites for the strand exhibiting the preferential platinum binding sites. The platinum moiety also coordinates to the other DNA strand, most likely leading only to mono guanine or adenine adducts.</p>
        <sec>
          <title>Electronic supplementary material</title>
          <p>The online version of this article (doi:10.1007/s00775-008-0346-y) contains supplementary material, which is available to authorized users.</p>
        </sec>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>Platinum</kwd>
        <kwd>Copper</kwd>
        <kwd>Heterodinuclear</kwd>
        <kwd>DNA</kwd>
        <kwd>Ditopic</kwd>
      </kwd-group>
      <custom-meta-wrap>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; SBIC 2008</meta-value>
        </custom-meta>
      </custom-meta-wrap>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Introduction</title>
      <p>DNA is a target for numerous antitumor drugs [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Reversible or irreversible modifications of the nucleic acids can lead to disruption of the transcription and/or replication, initiating ultimately the death of cancer cells. Cisplatin [<xref ref-type="bibr" rid="CR3">3</xref>] and bleomycin are among these efficient anticancer drugs [<xref ref-type="bibr" rid="CR4">4</xref>]. The mechanism of action is different for both drug substances; cisplatin primarily induces distortions upon binding to DNA, whereas bleomycin is able to generate DNA strand scissions.</p>
      <p>Since the discovery of bleomycin [<xref ref-type="bibr" rid="CR5">5</xref>], numerous metal complexes have been synthesized that are able to produce DNA cleavage. Typical examples are iron(II)&#x2013;edta complexes, manganese(III)&#x2013;porphyrin and Cu, Co, Ru and Rh complexes with phenanthroline [<xref ref-type="bibr" rid="CR6">6</xref>&#x2013;<xref ref-type="bibr" rid="CR9">9</xref>]. For instance, Cu(phen)<sub>2</sub><sup>+</sup> in the presence of dihydrogen peroxide efficiently cleaves double-stranded DNA through the oxidative attack on deoxyribose units from the minor groove [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. The consequent DNA-cleavage products include 5&#x2032;-monophosphate and 3&#x2032;-monophosphate ester termini, free bases, 5-methylene furanone, and a small amount of 3&#x2032;-phosphoglycolate [<xref ref-type="bibr" rid="CR12">12</xref>&#x2013;<xref ref-type="bibr" rid="CR14">14</xref>]. Dihydrogen peroxide can be generated by Cu(phen)<sub>2</sub><sup>2+</sup> in close proximity to the DNA strands, in the presence of a reductant and molecular oxygen [<xref ref-type="bibr" rid="CR15">15</xref>]. The nuclease activity of Cu(phen)<sub>2</sub> has been enhanced with the synthesis of 1-(1,10-phenanthrolin-3-yloxy)-3-(1,10-phenanthrolin-8-yloxy)propan-2-amine (3-Clip-Phen, <bold>4</bold>) based on the covalent linkage of two phenanthroline units through their 3-position, leading to an increase of 60 times compared with the nuclease activity of Cu(phen)<sub>2</sub> itself [<xref ref-type="bibr" rid="CR15">15</xref>]. However, similarly to Cu(phen)<sub>2</sub>, the copper complexes of 3-Clip-Phen have no sequence selectivity, and cleave the DNA in a single-stranded fashion. The amine group of 3-Clip-Phen has been functionalized with different groups, such as a distamycin analog or various DNA intercalators [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. Thus, the resulting complexes show enhanced cleaving activities, and the complexes with the distamycin analog exhibit excellent targeting properties toward A&#xB7;T boxes [<xref ref-type="bibr" rid="CR18">18</xref>].</p>
      <p>Recently, it has been shown that Cu(3-Clip-Phen) (<bold>3</bold>) attached to a cisplatin motif is able to perform direct double-strand cuts, thanks to the DNA-anchoring platinum moiety [<xref ref-type="bibr" rid="CR19">19</xref>]. Platinum complexes have received considerable attention since the discovery of the antiproliferate activity of cisplatin in 1969 [<xref ref-type="bibr" rid="CR20">20</xref>]. It is generally accepted that the distortion of DNA generated upon binding of cisplatin is largely responsible for its antitumor properties [<xref ref-type="bibr" rid="CR3">3</xref>]. Subsequent drug activation via intracellular aquation reactions results in a variety of stable bifunctional DNA&#x2013;platinum(II) adducts. 1,2-Intrastrand cross-links between two adjacent guanine bases d(GG) or between an adenine and a guanine residue d(AG) are primarily formed. The platinum center of complexes with a <italic>cis</italic> motif preferentially coordinates to the N7 position of both adenine and guanine in the major groove of DNA [<xref ref-type="bibr" rid="CR21">21</xref>&#x2013;<xref ref-type="bibr" rid="CR24">24</xref>].</p>
      <p>In the present paper, the preparation of a bifunctional complex [CuPt[<italic>N</italic><sup>1</sup>-(3-(1,10-phenanthrolin-3-yloxy)-1-(1,10-phenanthrolin-8-yloxy)propan-2-yl)ethane-1,2-diamine]Cl<sub>4</sub>, <bold>2</bold>] containing both a <italic>cis</italic>-bis(amine)Pt(II) moiety and a nuclease active 3-Clip-Phen group is reported (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). The bridge connecting the platinum and copper moieties is very short and therefore rigid in contrast to that in the previous report, where the complexes had flexible linkers in order to have a major&#x2013;minor groove interaction [<xref ref-type="bibr" rid="CR19">19</xref>]. The platinum and the 3-Clip-Phen adjacent parts are now separated by a short linker. Consequently, in this case either the platinum species will not interact with its preferential site (the major groove) or the 3-Clip-Phen moiety will not interact with its preferential site (the minor groove). The platinum component plays two roles: (1) it acts as a DNA anchor, thus allowing the Cu(3-Clip-Phen) moiety to perform cleavages in the close proximity of the Pt&#x2013;DNA adducts, and (2) it induces a sequence-selective binding of the heterodinuclear complex. Accordingly, the achievement of double-strand DNA breaks is potentially increased, because the single-strand cuts are in the close proximity of the platinum adduct and sequence-selective cleavage may be expected.
<fig id="Fig1"><label>Fig.&#xA0;1</label><caption><p>Complexes <bold>1</bold>&#x2013;<bold>3</bold></p></caption><graphic position="anchor" xlink:href="775_2008_346_Fig1_HTML" id="MO2"/></fig></p>
      <p>In the present study, the binding property of the platinum moiety and the cleavage selectivity and activity of this novel heterodinuclear complex <bold>2</bold> were investigated by agarose gel electrophoresis and high-resolution analysis with a 36-bp DNA fragment (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>). The results obtained are compared with those achieved with cisplatin and the Cu(3-Clip-Phen) complex.
<fig id="Fig2"><label>Fig.&#xA0;2</label><caption><p>Nucleobase sequences of oligonucleotide I (<italic>ODN I</italic>), oligonucleotide II (<italic>ODN II</italic>) and the primer used for the binding experiments. The preferential binding sites of cisplatin are indicated by <italic>arrowheads</italic></p></caption><graphic position="anchor" xlink:href="775_2008_346_Fig2_HTML" id="MO3"/></fig></p>
    </sec>
    <sec id="Sec2" sec-type="materials|methods">
      <title>Materials and methods</title>
      <sec id="Sec3">
        <title>Preparation of Pt[<italic>N</italic><sup>1</sup>-(3-(1,10-phenanthrolin-3-yloxy)-1-(1,10-phenanthrolin-8-yloxy)propan-2-yl)ethane-1,2-diamine]Cl<sub>2</sub> and <bold>2</bold></title>
        <p>All reagents and solvents were commercially available and used without further purification. Cu(3-Clip-Phen) (<bold>3</bold>) was prepared as previously described [<xref ref-type="bibr" rid="CR15">15</xref>]. The <sup>1</sup>H NMR chemical shifts of standard solvent molecules have been omitted in all redrawn spectra for clarity.</p>
      </sec>
      <sec id="Sec4">
        <title>2-(2-(3-(1,10-Phenanthrolin-3-yloxy)-1-(1,10-phenanthrolin-8-yloxy)propan-2-ylamino)ethyl)isoindoline-1,3-dione</title>
        <p>3-Clip-Phen (<bold>4</bold>) (100&#xA0;mg, 0.22&#xA0;mmol) was dissolved in 5&#xA0;mL of dimethylformamide (DMF). One equivalent of <italic>N</italic>-(2-bromoethyl)phthalimide (<bold>5</bold>) (56.7&#xA0;mg, 0.22&#xA0;mmol) and 1&#xA0;equiv of <italic>N</italic>-ethyldiisopropylamine (38&#xA0;&#x3BC;L, 0.22&#xA0;mmol) were added to <bold>4</bold>. The reaction mixture was heated to 100&#xA0;&#xB0;C for 2&#xA0;days. After the mixture had cooled to room temperature, 10&#xA0;mL of dichloromethane (DCM) was added, and the organic phase was washed three times with 10&#xA0;mL of distilled water. After being dried over Na<sub>2</sub>SO<sub>4</sub> and evaporation under reduced pressure, the resulting crude product was purified by column chromatography (SiO<sub>2</sub>, DCM, MeOH, NH<sub>4</sub>OH, 95:5:0.5), to yield 2-(2-(3-(1,10-phenanthrolin-3-yloxy)-1-(1,10-phenanthrolin-8-yloxy)propan-2-ylamino)ethyl)isoindoline-1,3-dione (<bold>6</bold>) as an off-white powder (yield&#xA0;34%). <sup>1</sup>H NMR (DCCl<sub>3</sub>, 300&#xA0;MHz) <italic>&#x3B4;</italic> 9.05 (dd, 2H, <italic>J</italic>&#xA0;=&#xA0;4.32, 1.67&#xA0;Hz), 8.81 (d, 2H, <italic>J</italic>&#xA0;=&#xA0;2.83&#xA0;Hz), 8.10 (dd, 2H, <italic>J</italic>&#xA0;=&#xA0;8.07, 1.62&#xA0;Hz), 7.72 (dd, 2H, <italic>J</italic>&#xA0;=&#xA0;5.43, 3.05&#xA0;Hz), 7.67 (d, 2H, <italic>J</italic>&#xA0;=&#xA0;8.88&#xA0;Hz), 7.62 (d, 2H <italic>J</italic>&#xA0;=&#xA0;8.86&#xA0;Hz), 7.54 (dd, 2H, <italic>J</italic>&#xA0;=&#xA0;6.09, 4.74&#xA0;Hz), 7.48 (m, 4H), 4.27 (d, 4H, <italic>J</italic>&#xA0;=&#xA0;5.18&#xA0;Hz), 3.84 (t, 2H, <italic>J</italic>&#xA0;=&#xA0;6.06&#xA0;Hz), 3.54 (m, 1H), 3.13 (t, 2H, <italic>J</italic>&#xA0;=&#xA0;6.12&#xA0;Hz) ppm. <sup>13</sup>C NMR (DCCl<sub>3</sub>, 75&#xA0;MHz) <italic>&#x3B4;</italic> 168.4, 153.7, 150.1, 146.0, 142.4, 140.3, 135.73, 133.8, 132.0, 129.3, 127.1, 125.9, 123.0, 122.0, 114.9, 67.3, 55.6, 45.4, 37.8&#xA0;ppm. Low-resolution mass spectrometry (MS) (electrospray ionization, ESI, more than 0) <italic>m</italic>/<italic>z</italic> 621.00 [(M&#xA0;+&#xA0;H)<sup>+</sup>; calcd for C<sub>37</sub>H<sub>29</sub>N<sub>6</sub>O<sub>4</sub><sup>+</sup>: 621.66], 642.94 [(M&#xA0;+&#xA0;Na)<sup>+</sup>; calcd for C<sub>37</sub>H<sub>28</sub>N<sub>6</sub>O<sub>4</sub>Na<sup>+</sup>: 643.65] Anal. calcd for C<sub>37</sub>H<sub>28</sub>N<sub>6</sub>O<sub>4</sub>&#xB7;1.6 H<sub>2</sub>O: C, 68.42; H, 4.84; N, 12.94. Found: C, 68.34; H, 4.86; N, 13.21.</p>
      </sec>
      <sec id="Sec5">
        <title><italic>N</italic><sup>1</sup>-(3-(1,10-Phenanthrolin-3-yloxy)-1-(1,10-phenanthrolin-8-yloxy)propan-2-yl)ethane-1,2-diamine</title>
        <p>Two equivalents of hydrazine (15.6&#xA0;&#x3BC;L, 0.32&#xA0;mmol) were added to a solution of <bold>6</bold> (100&#xA0;mg, 0.16&#xA0;mmol) in 5&#xA0;mL of pure ethanol. The mixture was refluxed overnight. The ethanol was evaporated under reduced pressure, and the crude product was purified by column chromatography (SiO<sub>2</sub>, DCM, MeOH, NH<sub>4</sub>OH, 90:10:1) to give <italic>N</italic><sup>1</sup>-(3-(1,10-phenanthrolin-3-yloxy)-1-(1,10-phenanthrolin-8-yloxy)propan-2-yl)ethane-1,2-diamine (<bold>7</bold>) as a light-brown powder (yield 73%). <sup>1</sup>H NMR (MeOD-<italic>d</italic><sub>3</sub>, 300&#xA0;MHz) <italic>&#x3B4;</italic> 9.00 (dd, 2H, <italic>J</italic>&#xA0;=&#xA0;4.41, 1.63&#xA0;Hz), 8.84 (d, 2H, <italic>J</italic>&#xA0;=&#xA0;2.84&#xA0;Hz), 8.34 (dd, 2H, <italic>J</italic>&#xA0;=&#xA0;8.10, 1.67&#xA0;Hz), 7.90 (d, 2H, <italic>J</italic>&#xA0;=&#xA0;2.86&#xA0;Hz), 7.83 (m, 4H), 7.65 (dd, 2H, <italic>J</italic>&#xA0;=&#xA0;8.10, 3.26&#xA0;Hz), 4.51 (d, 4H, <italic>J</italic>&#xA0;=&#xA0;4.47&#xA0;Hz), 3.58 (m, 1H), 3.07 (t, 2H, <italic>J</italic>&#xA0;=&#xA0;5.64&#xA0;Hz), 2.97 (t, 2H, <italic>J</italic>&#xA0;=&#xA0;5.23) ppm. <sup>13</sup>C NMR (MeOD-<italic>d</italic><sub>3</sub>, 75&#xA0;MHz) <italic>&#x3B4;</italic> 155.6, 150.6, 146.3, 143.0, 140.5, 137.6, 131.0, 128.7, 128.2, 127.4, 123.5, 116.7, 69.1, 57.5, 41.9&#xA0;ppm. Low-resolution MS (ESI&#xA0;&gt;&#xA0;0) <italic>m</italic>/<italic>z</italic> 490.98 [(M&#xA0;+&#xA0;H)<sup>+</sup>; calcd for C<sub>29</sub>H<sub>27</sub>N<sub>6</sub>O<sub>2</sub><sup>+</sup>: 491.56] Anal. calcd for C<sub>29</sub>H<sub>26</sub>N<sub>6</sub>O<sub>2</sub>&#xB7;1.9 CH<sub>2</sub>Cl<sub>2</sub>: C, 56.93; H, 4.61; N, 12.89. Found: C, 56.79; H, 5.13; N, 13.23.</p>
      </sec>
      <sec id="Sec6">
        <title>Pt[<italic>N</italic><sup>1</sup>-(3-(1,10-phenanthrolin-3-yloxy)-1-(1,10-phenanthrolin-8-yloxy)propan-2-yl)ethane-1,2-diamine]Cl<sub>2</sub></title>
        <p>To a solution of <bold>7</bold> (70.4&#xA0;mg, 0.14&#xA0;mmol) in 6.5&#xA0;mL of DMF was added a solution of 0.8&#xA0;equiv of K<sub>2</sub>PtCl<sub>4</sub> (47.69&#xA0;mg, 0.11&#xA0;mmol) in 3.25&#xA0;mL of de-ionized H<sub>2</sub>O. The reaction mixture was stirred for 6&#xA0;h at room temperature. The off-white precipitate was filtered off and washed with 30&#xA0;mL of deionized water, 30&#xA0;mL of MeOH and 20&#xA0;mL of diethyl ether to give Pt[<italic>N</italic><sup>1</sup>-(3-(1,10-phenanthrolin-3-yloxy)-1-(1,10-phenanthrolin-8-yloxy)propan-2-yl)ethane-1,2-diamine]Cl<sub>2</sub> (<bold>1</bold>) as an off-white powder (yield 42%). <sup>1</sup>H NMR (DMSO-<italic>d</italic><sub>6</sub>, where DMSO is dimethyl sulfoxide, 300&#xA0;MHz) <italic>&#x3B4;</italic> 9.04 (d, 2H, <italic>J</italic>&#xA0;=&#xA0;2.77&#xA0;Hz), 8.88 (d, 2H, <italic>J</italic>&#xA0;=&#xA0;2.45&#xA0;Hz), 8.45 (d, 2H, <italic>J</italic>&#xA0;=&#xA0;8.00&#xA0;Hz), 8.05 (br, 2H), 7.95 (m, 4H), 7.70 (dd, 2H, <italic>J</italic>&#xA0;=&#xA0;7.99, 4.35&#xA0;Hz), 4.49 (br, 4H), 4.07 (br, 5H) ppm. <sup>195</sup>Pt NMR (DMSO-d<sub>6</sub>) <italic>&#x3B4;</italic> &#x2212;2,317 (complex), &#x2212;3,292 (complex with one DMSO coordinated) ppm. IR (neat): <italic>&#x3BD;</italic>&#xA0;=&#xA0;3,049 (br); 1,591 (s); 1,506 (s); 1,424 (s); 1,236 (s); 1,198 (s); 1,102 (s); 1,018 (s); 876 (s), 834 (s), 728 (s), 332 (s), 325 (s)&#xA0;cm<sup>&#x2212;1</sup>. Anal. calcd for C<sub>29</sub>H<sub>26</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>2</sub>Pt&#xB7;DMF: C, 46.33; H, 4.01; N, 11.82 Found: C, 47.54; H, 4.43; N; 11.70; the deviation in calculated percentage C is ascribed to traces of solvent other than DMF.</p>
      </sec>
      <sec id="Sec7">
        <title>CuPt[N<sup><italic>1</italic></sup>-(3-(1,10-phenanthrolin-3-yloxy)-1-(1,10-phenanthrolin-8-yloxy)propan-2-yl)ethane-1,2-diamine]Cl<sub>4</sub></title>
        <p>CuCl<sub>2</sub> (17.0&#xA0;mg, 0.1&#xA0;mmol) was added as a solid to a suspension of <bold>1</bold> (75.7&#xA0;mg, 0.1&#xA0;mmol) in DMF (25&#xA0;mL). The reaction was stirred overnight at 50&#xA0;&#xB0;C. DMF was partially evaporated under reduced pressure, and the crude compound was precipitated in 100&#xA0;mL of diethyl ether. The solid material was filtered off and washed with 3&#xA0;&#xD7;&#xA0;20&#xA0;mL of diethyl ether, and dried overnight at 50&#xA0;&#xB0;C under reduced pressure to give <bold>2</bold> as a green powder (yield 93%). X-band electron paramagnetic resonance (solid state): <italic>g</italic>&#xA0;=&#xA0;2.1191. UV&#x2013;vis (H<sub>2</sub>O) <italic>&#x3BB;</italic><sub>max</sub> 282 (40,100), 321 (12,500), 333 (10,100), 347 (3,280) &#xA0;nm. High-resolution MS (<italic>m</italic>/<italic>z</italic>): [2M&#x2013;2Cl] calcd for (C<sub>58</sub>H<sub>52</sub>Cl<sub>6</sub>N<sub>12</sub>O<sub>4</sub>Pt<sub>2</sub>Cu<sub>2</sub>)<sup>2+</sup> 853.00852, 853.5096, 854.0097, 854.5087, 855.0088, 855.5072, 856.0073, 856.5083, 857.0100, 857.5067; found 853.0117, 853.5117, 854.0114, 854.5110, 855.0107, 855.5105, 856.0103, 856.5101, 857.0098, 857.5097.</p>
      </sec>
      <sec id="Sec8">
        <title>Cytotoxicity</title>
        <p>The cytotoxicity of complexes <bold>1</bold> and <bold>2</bold> has been determined for breast (MCF7), two glioblastoma (Hs683 and U373), two colorectal (HCT-15 and LoVo) and lung (A549) cancer cell lines (see supplementary material for experimental details and results).</p>
      </sec>
      <sec id="Sec9">
        <title>Solutions of complexes for experiments with DNA</title>
        <p>One millimolar DMSO solutions of the complexes investigated were prepared, and were subsequently diluted with Milli-Q water.</p>
      </sec>
      <sec id="Sec10">
        <title>Nuclease activity on supercoiled DNA</title>
        <p>One millimolar DMSO solutions of the complexes investigated were diluted to, respectively, 200, 400 and 1,000&#xA0;nM with Milli-Q water. Five microliters of the complex solution was added to 10&#xA0;&#x3BC;L of supercoiled &#x3A6;X174 DNA (Invitrogen, 7&#xA0;nM, 40&#xA0;&#x3BC;M base pairs) in 6&#xA0;mM NaCl, 20&#xA0;mM sodium phosphate buffer (pH 7.2), and incubated for 20&#xA0;h at 37&#xA0;&#xB0;C. To initiate the cleavage, 5&#xA0;&#x3BC;L of a 20&#xA0;mM mercaptopropionic acid solution in water was added, and the resulting reaction mixture was incubated at 37&#xA0;&#xB0;C for 1&#xA0;h. The reaction was quenched at 4&#xA0;&#xB0;C, followed by the addition of 4&#xA0;&#x3BC;L of loading buffer (glycerol with bromophenol blue) prior to the loading on a 0.8% agarose gel containing 1&#xA0;&#x3BC;g&#xA0;mL<sup>&#x2212;1</sup> ethidium bromide. The gels were run at a constant voltage of 70&#xA0;V for 90&#xA0;min in 2-amino-2-(hydroxymethyl)propane-1,3-diol (Tris) borate edta (TBE) buffer containing 1&#xA0;&#x3BC;g&#xA0;mL<sup>&#x2212;1</sup> ethidium bromide. The gels were visualized under a UV transilluminator, and the bands were quantified using a Bio-Rad Gel Doc 1000 apparatus interfaced with a computer.</p>
      </sec>
      <sec id="Sec11">
        <title>Time-course experiments of DNA cleavage</title>
        <p>Fifty microliters of the complex solution was added to 100&#xA0;&#x3BC;L of supercoiled &#x3A6;X174 DNA (Invitrogen, 7&#xA0;nM, 40&#xA0;&#x3BC;M base pairs) in 6&#xA0;mM NaCl, 20&#xA0;mM sodium phosphate buffer (pH 7.2), and the resulting reaction mixture was incubated for 20&#xA0;h at 37&#xA0;&#xB0;C. To initiate the cleavage, 50&#xA0;&#x3BC;L of 20&#xA0;mM mercaptopropionic acid was added, and a sample was taken out every 10&#xA0;min. Four microliters of loading buffer (glycerol with bromophenol blue) was added, and the sample was directly frozen in liquid nitrogen. When all samples had been collected, they were loaded on a 0.8% agarose gel containing 1&#xA0;&#x3BC;g&#xA0;mL<sup>&#x2212;1</sup> ethidium bromide.</p>
      </sec>
      <sec id="Sec12">
        <title>Analyses with 5&#x2032;-<sup>32</sup>P-end-labeled DNA</title>
        <p>Oligonucleotides (ODNs) I and II and the primer (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>) were purchased from Eurogentec, and purified on a 15% polyacrylamide (acrylamide to bisacrylamide ratio 19:1) gel. The denaturating gel contained 7&#xA0;M urea. The migrations was performed in the presence of TBE buffer at 2,500&#xA0;V for 3&#xA0;h. The concentrations of single-stranded ODNs were determined by UV titration at 260&#xA0;nm [<xref ref-type="bibr" rid="CR25">25</xref>]. The ODNs were end-labeled with <sup>32</sup>P using standard procedures with T<sub>4</sub> polynucleotide kinase (New England BioLabs) and [&#x3B3;-<sup>32</sup>P]ATP for the 5&#x2032;-end, before being purified on a MicroSpin G25 column (Pharmacia) [<xref ref-type="bibr" rid="CR26">26</xref>].</p>
      </sec>
      <sec id="Sec13">
        <title>Comparison of the platinum&#x2013;ODN adducts formed with the different complexes</title>
        <p>5&#x2032;-end-labeled ODN I (2&#xA0;&#x3BC;M) was annealed to 1&#xA0;equiv of its complementary strand ODN II in 1,100&#xA0;&#x3BC;L of Tris&#x2013;HCl (20&#xA0;mM, pH 7.2) by heating to 90&#xA0;&#xB0;C for 5&#xA0;min, followed by slow cooling to room temperature. Then, 60&#xA0;&#x3BC;L of this solution was incubated with 60&#xA0;&#x3BC;L of the complex solution (6 or 20&#xA0;&#x3BC;M) for 20&#xA0;h at 37&#xA0;&#xB0;C, followed by precipitation with 100&#xA0;&#x3BC;L of sodium acetate buffer (3&#xA0;M, pH 5.2) and 1,300&#xA0;&#x3BC;L of cold ethanol. Pellets were rinsed with ethanol and lyophilized. Samples were dissolved in formamide containing bromophenol blue and xylene cyanol and heated for 3&#xA0;min at 90&#xA0;&#xB0;C before being loaded on the gel. Platinum&#x2013;DNA adducts were analyzed by denaturing 20% polyacrylamide gel electrophoresis, then by phosphorimagery.</p>
      </sec>
      <sec id="Sec14">
        <title>Comparison of the sequence-selective binding by primer extension experiments with <italic>Taq</italic> polymerase</title>
        <p>ODN I (2&#xA0;&#x3BC;M) was annealed to ODN II (2&#xA0;&#x3BC;M) in 1,100&#xA0;&#x3BC;L of Tris&#x2013;HCl (20&#xA0;mM, pH 7.2) by heating to 90&#xA0;&#xB0;C for 5&#xA0;min, followed by slow cooling to room temperature. Sixty microliters of this solution was then incubated with 60&#xA0;&#x3BC;L of the complex solution (6 or 20&#xA0;&#x3BC;M) for 20&#xA0;h at 37&#xA0;&#xB0;C, followed by precipitation with 100&#xA0;&#x3BC;L of sodium acetate buffer (3&#xA0;M, pH 5.2) and 1,300&#xA0;&#x3BC;L of cold ethanol. Pellets were rinsed with ethanol and lyophilized. For primer extension, an aliquot of the redissolved samples (0.25&#xA0;&#x3BC;M) was annealed with 5&#x2032;-end-labeled primer (0.25&#xA0;&#x3BC;M) and 1 equiv of ODN I (0.25&#xA0;&#x3BC;M) in the enzyme buffer (the buffer contains a small amount of reductant, but not enough to induce DNA cleavage by complex <bold>2</bold>) before the addition of 250&#xA0;&#x3BC;M dGTP, dCTP, dATP and dTTP and 2.5&#xA0;U of <italic>Taq</italic> polymerase (final concentrations are given, the total volume was 10&#xA0;&#x3BC;L). One equivalent of unmodified ODN I was added in order to displace the ODN II from the duplex and replace it with the labeled primer. The samples were reacted at 37&#xA0;&#xB0;C for 30&#xA0;min, and 1&#xA0;&#x3BC;L of edta (0.2&#xA0;M) was subsequently added. Samples were dissolved in formamide containing bromophenol blue and xylene cyanol and heated for 3&#xA0;min at 90&#xA0;&#xB0;C, before being loaded on the gel. Five microliters of sample was then analyzed by denaturing 20% polyacrylamide gel electrophoresis and phosphorimagery. The Maxam and Gilbert [<xref ref-type="bibr" rid="CR27">27</xref>] sequencing scale, including a final scale of T4 polynucleotide kinase digestion to remove 3&#x2032;-end phosphates, was used to analyze the DNA fragments. The sequencing experiments show, in addition to a strong, easily assigned G signal, also a weak A signal.</p>
      </sec>
      <sec id="Sec15">
        <title>Comparison of the cleavage patterns of ODN I&#x2013;ODN II induced by the copper complexes</title>
        <p>The 5&#x2032;-end-labeled 36mer target (2&#xA0;&#x3BC;M) was annealed to 1 equiv of its complementary strand in 1,100&#xA0;&#x3BC;L of Tris&#x2013;HCl (20&#xA0;mM, pH 7.2) by heating to 90&#xA0;&#xB0;C for 5&#xA0;min, followed by slow cooling to room temperature. To 60&#xA0;&#x3BC;L of this solution was added 60&#xA0;&#x3BC;L of complex <bold>1</bold>, <bold>2</bold> or <bold>3</bold> solutions (20&#xA0;&#x3BC;M). Some of the samples involving complex <bold>2</bold> were incubated for 19&#xA0;h, followed by the addition of 1&#xA0;equiv of CuCl<sub>2</sub> per complex and subsequent incubation (1&#xA0;h). The other samples were incubated for 20&#xA0;h at 37&#xA0;&#xB0;C. Next, all samples were precipitated with 100&#xA0;&#x3BC;L of sodium acetate buffer (3&#xA0;M, pH 5.2) and 1,300&#xA0;&#x3BC;L of cold ethanol. Pellets were rinsed with ethanol and lyophilized, then dissolved to 1.33&#xA0;&#x3BC;M in Tris&#x2013;HCl buffer (13.3&#xA0;mM, pH 7.4). For the cleavage experiments, to 15&#xA0;&#x3BC;L of this solution was added 5&#xA0;&#x3BC;L of a 0.8&#xA0;mM ascorbate solution (5&#xA0;&#x3BC;L of water was added to the controls). The samples were incubated at 37&#xA0;&#xB0;C for 1&#xA0;h, followed by precipitation in 20&#xA0;&#x3BC;L of sodium acetate buffer (3&#xA0;M, pH 5.2) containing 1&#xA0;&#x3BC;g of salmon testes DNA and 180&#xA0;&#x3BC;L of cold ethanol. Pellets were rinsed with ethanol and lyophilized. In order to study the DNA cleavage mechanism, additional treatments were performed on some samples: (1) heating at 90&#xA0;&#xB0;C in 50&#xA0;&#x3BC;L of 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)&#x2013;NaOH buffer (0.1&#xA0;M, pH 8.0) for 30&#xA0;min, followed by ethanol precipitation; (2) heating at 90&#xA0;&#xB0;C in 50&#xA0;&#x3BC;L of piperidine (0.2&#xA0;M in water) for 30&#xA0;min, followed by lyophilization. Samples were dissolved in formamide containing bromophenol blue and xylene cyanol and heated for 3&#xA0;min at 90&#xA0;&#xB0;C, before being loaded on the gel. Samples were analyzed by denaturing 20% polyacrylamide gel electrophoresis, then phosphorimagery. The Maxam and Gilbert [<xref ref-type="bibr" rid="CR27">27</xref>] sequencing scale was used to analyze DNA fragments. The sequencing experiments show, in addition to a strong, easily assigned G signal, also a weak A signal.</p>
      </sec>
    </sec>
    <sec id="Sec16" sec-type="results">
      <title>Results and discussion</title>
      <sec id="Sec17">
        <title>Design and synthesis of a heterodinuclear platinum&#x2013;copper complex</title>
        <p>A ditopic ligand <bold>7</bold> was designed to favor the simultaneous coordination of a platinum and a copper entity; hence, the resulting bifunctional complex would combine the ability to form a kinetically inert coordination bond with DNA, thanks to its <italic>cis</italic>-Pt moiety, with the cleavage properties of Cu(3-Clip-Phen). Two coordination compounds, namely, the platinum complex <bold>1</bold> and the heterodinuclear platinum&#x2013;copper complex <bold>2</bold> (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>) were prepared with the ligand <bold>7</bold>. The binding ability of the platinum unit and the cleavage selectivity of the Cu(3-Clip-Phen) moiety were investigated. The results were compared with those for the known Cu(3-Clip-Phen) complex (<bold>3</bold>). The short separation between the Pt and the Cu centers in complex <bold>2</bold> most likely affects the preference for platinum to bind in the major groove, and in the minor groove for copper. Accordingly, the coordination of the platinum moiety in the major groove will force the Cu(3-Clip-Phen) component to bind in the major groove, and vice versa.</p>
        <p>The general synthetic pathway to prepare complexes <bold>1</bold> and <bold>2</bold> is depicted in Scheme&#xA0;<xref rid="Sch1" ref-type="fig">1</xref>. The selective and complete platination of the ethylenediamine unit using 1&#xA0;equiv of K<sub>2</sub>PtCl<sub>4</sub> was monitored by <sup>195</sup>Pt&#xA0;NMR and <sup>1</sup>H NMR. The in situ reaction of the resulting platinum derivative <bold>1</bold> with 1&#xA0;equiv of CuCl<sub>2</sub> produces the heterobimetallic complex <bold>2</bold>.
<fig id="Sch1"><label>Scheme&#xA0;1</label><caption><p>Preparation of complexes <bold>1</bold> and <bold>2</bold>. Reagents and conditions as follows: <italic>i</italic> dimethylformamide (DMF), diisopropylethylamine, 100&#xA0;&#xB0;C, 2&#xA0;days; <italic>ii</italic> ethanol, H<sub>2</sub>N&#x2013;NH<sub>2</sub>, reflux, overnight; <italic>iii</italic> K<sub>2</sub>PtCl<sub>4</sub>, MeOH/water, room temperature, 6&#xA0;h; <italic>iv</italic> CuCl<sub>2</sub>, DMF, 50&#xA0;&#xB0;C, overnight</p></caption><graphic position="anchor" xlink:href="775_2008_346_Sch1_HTML" id="MO1"/></fig></p>
      </sec>
      <sec id="Sec18">
        <title>Cleavage of supercoiled DNA</title>
        <p>The relaxation of supercoiled circular &#x3A6;X174 DNA (form I) into its relaxed (form II) and linear (form III) conformations was monitored to compare the aerobic cleavage abilities of complexes <bold>2</bold> and <bold>3</bold>, in the presence of a reducing agent (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>). First, the complexes were incubated for 20&#xA0;h, to allow the formation of platinum&#x2013;DNA adducts. The nuclease activity was subsequently initiated by the addition of 5&#xA0;mM mercaptopropionic acid. Complex <bold>2</bold> exhibits a markedly higher nuclease activity than Cu(3-Clip-Phen) (<bold>3</bold>) (compare lanes 5 and 9 in Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>). Indeed, at complex concentrations of 100&#xA0;nM, most supercoiled DNA has reacted to form circular and linear DNA in the case of <bold>2</bold>, while Cu(3-Clip-Phen) only generates a small amount of form II (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>, lanes 4 and 8). Moreover, almost all the DNA has reacted to form smaller DNA fragments (migrating as a smear) at a complex concentration of 250&#xA0;nM for <bold>2</bold> (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>, lane 5), whereas no smear is observed for Cu(3-Clip-Phen) (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>, lane 9). Interestingly, at a concentration of 100&#xA0;nM for complex <bold>2</bold>, form III is detected before the total disappearance of form I (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>, lane 4) [<xref ref-type="bibr" rid="CR19">19</xref>]. This result indicates that the heterodinuclear platinum&#x2013;copper complex is able to perform direct double-strand cuts since form I is still detected in the reaction. Such double-strand breaks are highly cytotoxic, since the cells have difficulties to repair such damage [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. Cu(3-Clip-Phen) is only able to perform repetitive single-strand cuts [<xref ref-type="bibr" rid="CR15">15</xref>]. Interestingly, the cleavage activity of complex <bold>2</bold> is also more efficient compared with that of the platinum&#x2013;copper complexes previously reported by our group [<xref ref-type="bibr" rid="CR19">19</xref>].
<fig id="Fig3"><label>Fig.&#xA0;3</label><caption><p>Comparative experiments of the oxidative cleavage of &#x3A6;X174 plasmid DNA performed by <bold>2</bold> and <bold>3</bold>. <italic>Lane 1</italic> control DNA. <italic>Lane 2</italic> 250&#xA0;nM solution of <bold>2</bold>. <italic>Lane 3</italic> 50&#xA0;nM <bold>2</bold>, in the presence of 5&#xA0;mM mercaptopropionic acid (MPA). <italic>Lane 4</italic> 100&#xA0;nM <bold>2</bold>, in the presence of 5&#xA0;mM MPA. <italic>Lane 5</italic> 250&#xA0;nM <bold>2</bold>, in the presence of 5&#xA0;mM MPA. <italic>Lane 6</italic> 250&#xA0;nM <bold>3</bold>. <italic>Lane 7</italic> 50&#xA0;nM <bold>3</bold>, in the presence of 5&#xA0;mM MPA. <italic>Lane 8</italic> 100&#xA0;nM <bold>3</bold>, in the presence of 5&#xA0;mM MPA. <italic>Lane 9</italic> 250&#xA0;nM <bold>3</bold>, in the presence of 5&#xA0;mM MPA</p></caption><graphic position="anchor" xlink:href="775_2008_346_Fig3_HTML" id="MO4"/></fig></p>
        <p>Time-course studies of DNA cleavage by complexes <bold>2</bold> and <bold>3</bold> were carried out to further investigate the direct double-strand cleavage event (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>). Complex <bold>3</bold> at a concentration of 250&#xA0;nM generates a maximum of 80% of circular DNA (form II) after a reaction time of about 1&#xA0;h [<xref ref-type="bibr" rid="CR19">19</xref>]. Around 20% of linear DNA (form III) is produced via the action of <bold>3</bold> after 70&#xA0;min. Remarkably, the formation of form III is only observed after a reaction time of 30&#xA0;min when already 60% of form II has been produced. For a 150&#xA0;nM solution of complex <bold>2</bold>, linear DNA (form III) is generated from the initial stages of the cleavage reaction, with supercoiled DNA (form I) still being present (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>). Also, only a maximum of 60% of form II is generated. These features reflect the ability of <bold>2</bold> to perform direct double-strand breaks, most likely as a result of the binding of the platinum moiety to DNA, allowing the copper part to achieve more than one oxidative cleavage in the close proximity of the platinum coordination site.
<fig id="Fig4"><label>Fig.&#xA0;4</label><caption><p>Time-course experiments of DNA cleavage (20&#xA0;&#x3BC;M in base pairs) over a period of 70&#xA0;min. Complex <bold>2</bold> (150&#xA0;nM) was incubated for 24&#xA0;h, followed by activation with 5&#xA0;mM MPA and air</p></caption><graphic position="anchor" xlink:href="775_2008_346_Fig4_HTML" id="MO5"/></fig></p>
      </sec>
      <sec id="Sec19">
        <title>Analysis of the platinum adducts on ODN&#xA0;I of the ODN&#xA0;I&#x2013;ODN&#xA0;II duplex target</title>
        <p>High-resolution analyses with a 36-bp DNA duplex (ODN&#xA0;I&#x2013;ODN II) were performed to investigate the coordination of the platinum component of the bifunctional complexes to DNA, (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>a). The sequence of this duplex was chosen to include GG and AG sites (which are the two major binding sites of <italic>cis</italic>-Pt(II) complexes) on one strand (ODN I). The results obtained after incubation of the complexes with the duplex labeled on the 5&#x2032;-end of ODN I for 24&#xA0;h were analyzed by polyacrylamide gel electrophoresis under denaturing conditions and are shown in Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>a. Denaturing conditions allowed the analysis of the Pt&#x2013;DNA adducts on ODN I of the duplex.
<fig id="Fig5"><label>Fig.&#xA0;5</label><caption><p><bold>a</bold> Polyacrylamide gel electrophoresis (PAGE) analysis of the Pt&#x2013;ODN I adducts of the ODN&#xA0;I&#x2013;ODN&#xA0;II duplex target (1&#xA0;&#x3BC;M). ODN I was 5&#x2032;-end-labeled with <sup>32</sup>P-phosphate. The complexes were incubated with the DNA for 24&#xA0;h before analyses. <italic>Lane 1</italic> ODN I. <italic>Lane 2</italic> 3&#xA0;&#x3BC;M cisplatin. <italic>Lane 3</italic> 10&#xA0;&#x3BC;M cisplatin. <italic>Lane 4</italic> 3&#xA0;&#x3BC;M <bold>1</bold>. <italic>Lane 5</italic> 10&#xA0;&#x3BC;M <bold>1</bold>. <italic>Lane 6</italic> 3&#xA0;&#x3BC;M <bold>2</bold>. <italic>Lane 7</italic> 10&#xA0;&#x3BC;M <bold>2</bold>. <bold>b</bold> Phosphorimager data of a DNA sequencing gel comparing the sequence specificity of cisplatin, <bold>1</bold> and <bold>2</bold>. All the samples were extended using <italic>Taq</italic> polymerase, starting from the 5&#x2032;-end-labeled primer. <italic>Lane 1</italic> blank experiment; <italic>Lane 2</italic> 3&#xA0;&#x3BC;M cisplatin; <italic>Lane 3</italic> 10&#xA0;&#x3BC;M <bold>1</bold>. <italic>Lane 4</italic> 10&#xA0;&#x3BC;M <bold>2</bold>. It is noteworthy that the GTA and GGAC sites give the sequence of the opposite strand that induced the stopping of the primer extension (Figs.&#xA0;S1, S2). <bold>c</bold> Nucleobase sequence of ODN I, and indication of the damage sites induced by cisplatin, <bold>1</bold> and <bold>2</bold>. <italic>Large arrows</italic> and <italic>small arrows</italic> represent, respectively, major and minor stop sites</p></caption><graphic position="anchor" xlink:href="775_2008_346_Fig5_HTML" id="MO6"/></fig></p>
        <p>Molecules able to irreversibly bind to DNA will retard the rate of migration of the modified ODN, compared with that of the free ODN; therefore, ODN&#x2013;Pt adducts appear as retarded bands on gels. The incubation with 3&#xA0;equiv of cisplatin clearly reveals an impeded mobility of the ensuing cisplatin&#x2013;ODN I adduct (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>a, lane 2). Only traces of free ODN I were detected; 89% of the ODN I had been modified. The incubation of the DNA duplex with 10&#xA0;equiv of cisplatin results in a total conversion of ODN I (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>a, lane 3). Complex <bold>1</bold> shows the formation of Pt&#x2013;ODN I adducts (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>a, lanes 4 and 5). Two distinct bands are clearly observed when 10&#xA0;equiv of complex <bold>1</bold> is incubated with the DNA target, indicating the formation of Pt&#x2013;ODN I adducts. The quantification of free ODN I reveals that as much as 84% of this DNA fragment has reacted. The use of complex <bold>2</bold> leads to comparable results, with the conversion of 88% of the initial ODN I (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>a, lane 7). However, the reaction between ODN I and complex <bold>2</bold> produces a smear (i.e., a range of products) on the gel. Our previously reported compounds showed reduced formation of Pt&#x2013;ODN adducts under similar experimental conditions compared with complexes <bold>1</bold> and <bold>2</bold> [<xref ref-type="bibr" rid="CR19">19</xref>].</p>
      </sec>
      <sec id="Sec20">
        <title>Sequence selective binding of complexes <bold>1</bold> and <bold>2</bold> compared with cisplatin</title>
        <p>Primer extension experiments were performed to investigate the sequence-selective binding of the platinum units to the ODN I fragment of the ODN I&#x2013;ODN II DNA duplex (Figs.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>b, c, S1, S2). The platinum complexes that did not react with DNA were removed prior to the start of the primer extension experiments. Nevertheless, it is possible to have more than one platinum moiety coordinating the ODN strand, since the concentrations of cisplatin, complex <bold>1</bold> and complex&#xA0;<bold>2</bold> were, respectively 3 and 10&#xA0;times higher than the concentration of the ODN I&#x2013;ODN II DNA duplex. <italic>Taq</italic> polymerase has proven to be a valuable tool for the determination of the sequence selectivity of various platinum complexes [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR30">30</xref>&#x2013;<xref ref-type="bibr" rid="CR39">39</xref>]. Cisplatin inhibits the enzymatic polymerization at the anticipated GG and AG sites (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>b, c), but the majority of cisplatin is detected at the GG site. It should be noted that once the ODN I strand contains two Pt adducts on both the GG and AG site, the enzyme stops only at the GG site. Therefore, it is possible that the amount of modified AG sites is underestimated. Nevertheless, not all of the ODN I has been modified by the complexes (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>a). It is therefore reasonable to say that the majority of the ODN I contains only one Pt adduct and that the AG site is indeed the minor site of interaction. The stop sites observed for complex <bold>1</bold> are also located for a major part at the GG base pairs and for a minor part at the AG base pairs. Complex <bold>2</bold> shows only stops at the GG binding site. These results indicate that the platinum moiety interacts with its preferential binding site. The difference between cisplatin and complexes <bold>1</bold> and <bold>2</bold> is the precise point at which the peak intensity occurs at the damaged site. The stops of the <italic>Taq</italic> polymerase are mainly located at the A base before the GG site for cisplatin, complex <bold>1</bold> and complex&#xA0;<bold>2</bold>. However, the enzyme stops induced at the GG site are more equally distributed among the GAC site in the cases of complexes <bold>1</bold> and <bold>2</bold> (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>b, c; the size of the arrows is an indication of the damage intensity). The binding of complexes <bold>1</bold> and <bold>2</bold> apparently produces bulky adducts, thus allowing a partial stop at the second nucleotide before the classic position, at the GG adduct, since an increase of the reaction time with the enzyme (from 30 to 120&#xA0;min, Fig.&#xA0;S3; complex <bold>1</bold>) induces a bypass of the stop at the C base (associated with a decrease of the peak intensity when compared with that for G). The difference between cisplatin and complex <bold>1</bold> is more pronounced at the AG site. Although it is the minor binding site, the damage induced by cisplatin almost exclusively takes place at the G base, at the 5&#x2032;-end of ODN I. The <italic>Taq</italic> polymerase stops for complex <bold>1</bold> are mainly observed at the A base.</p>
      </sec>
      <sec id="Sec21">
        <title>Cleavage of the ODN I strand of the ODN I&#x2013;ODN II duplex</title>
        <p>The cleavage of the ODN I&#x2013;ODN II duplex with complexes <bold>1</bold>&#x2013;<bold>3</bold> was investigated by polyacrylamide gel electrophoresis, the target being labeled on the 5&#x2032;-end of ODN I (Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6</xref>). To the best of our knowledge, studies of such bifunctional complexes have been reported only twice [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref>].
<fig id="Fig6"><label>Fig.&#xA0;6</label><caption><p><bold>a</bold> PAGE analysis of cleavage of ODN I of the ODN I&#x2013;ODN II duplex (1&#xA0;&#x3BC;M) by compounds <bold>1</bold>&#x2013;<bold>3</bold> (10&#xA0;&#x3BC;M when unspecified). The cleavage reactions were initiated with ascorbate (200&#xA0;&#x3BC;M) in aerobic conditions or by heating for 30&#xA0;min at 90&#xA0;&#xB0;C in aqueous 0.2&#xA0;M piperidine. The Maxam&#x2013;Gilbert sequencing reactions A&#xA0;+&#xA0;G (<italic>lane 1</italic>) and G (<italic>lane 2</italic>) were performed to determine the cleavage sites. On the top of the gel are indicated the conditions used during the experiments (details are given in &#x201C;<xref rid="Sec2" ref-type="sec">Materials and methods</xref>&#x201D;). Lanes 3&#x2013;6 are for controls without complexes. Lanes 17&#x2013;22 are for experiments that were performed in the presence of 1&#xA0;&#x3BC;M <bold>3</bold>. <bold>b</bold> High-contrast picture of lanes 8, 10, 11, 13, 15 and 16 in <bold>a</bold> allowing easier observation of the the cleavage pattern. &#x394;pH 8 was a heating step of 30&#xA0;min at 90&#xA0;&#xB0;C in 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)&#x2013;NaOH buffer (0.1&#xA0;M, pH 8.0). Unlinked complexes <bold>1</bold> and <bold>2</bold> were removed in a precipitation step with ethanol before the induction of cleavage</p></caption><graphic position="anchor" xlink:href="775_2008_346_Fig6_HTML" id="MO7"/></fig></p>
        <p>Complexes <bold>1</bold> and <bold>2</bold> were preincubated for 20&#xA0;h to allow the coordination of the platinum moiety to the DNA target. For complex <bold>1</bold>, the preincubation was subsequently followed by the coordination of 1&#xA0;equiv of copper, since the copper-free complex does not show any nuclease activity. The noncoordinated complexes were removed by precipitation before the cleavage was initiated by the addition of ascorbic acid (0.2&#xA0;mM) under aerobic conditions. Additional treatments (HEPES pH 8.0 and piperidine) were carried out.</p>
        <p>The noncovalent interaction of Cu(3-Clip-Phen) (<bold>3</bold>) with DNA permits its abstraction from the ODNs by a simple precipitation step. A tenfold excess of <bold>3</bold> (compared with the ODNs) does not generate cleavage products after the precipitation step (Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6</xref>, lane 24), while 1&#xA0;equiv of <bold>3</bold> without precipitation exhibits significant cleavage (Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6</xref>, lane 20). The platinum-containing complexes <bold>1</bold> and <bold>2</bold> form kinetically inert bonds with DNA, and therefore cannot be removed from the ODN during the precipitation step. In contrast, the unreacted complexes are eliminated.</p>
        <p>As expected, the cleavage pattern of <bold>3</bold> is nonspecific, [<xref ref-type="bibr" rid="CR18">18</xref>] as about 20% of the target is oxidized at all nucleotides (Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6</xref>, lane 20). The cleavage achieved by complex <bold>2</bold> in the presence of ascorbic acid results in the full and partial disappearance of, respectively, the Pt&#x2013;ODN I adducts and the ODN I band (Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6</xref>, lane 10). The total cleavage amounts to nearly 80%, and its pattern is different from the features resulting from the action of <bold>3</bold>, but no clear sequence selectivity is observed. Accordingly, a smear of products is noted in contrast to <bold>3</bold>, suggesting that the mechanism of the cleavage is different. This observation may be explained by either of the following possibilities: (1) some cuts are due to platinum adducts of complex <bold>2</bold> positioned on the other strand of the duplex (ODN II); (2) the extensive cleavage observed most likely indicates that the ODN I fragment experiences more than one cut; therefore, complex <bold>2</bold> should have been released after repetitive cuts from ODN I and should be able to cut the free ODN.</p>
        <p>To verify this hypothesis, the experimental conditions were adjusted to introduce fewer platinum adducts onto the target (20% against the 80% of modification of ODN I shown in Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6</xref>), and less ascorbate (100&#xA0;&#x3BC;M) was used to limit the recleavage events. However, the resulting cleavage pattern appears to be similar to that observed with the former conditions (Fig.&#xA0;<xref rid="Fig8" ref-type="fig">8</xref>).</p>
        <p>One equivalent of CuCl<sub>2</sub> was added to complex <bold>1</bold>, after the formation of Pt&#x2013;DNA adducts, to analyze the cleavage selectivity of the resulting compound. A comparatively less efficient cleavage was achieved using complex <bold>1</bold> with extra added CuCl<sub>2</sub>, when compared with complex <bold>2</bold> (compare lanes 10 and 15 in Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6</xref>), possibly as a result of the partial coordination of the copper ions to <bold>1</bold>. Similarly to <bold>2</bold>, the cleavage pattern obtained with <bold>1</bold> is found to be significantly different from that of <bold>3</bold> (Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6</xref>, lane 20). Interestingly, the free ODN I is not affected during the cleavage process, as only the ODN fragments containing platinum adducts are cleaved. Furthermore, a sequence-selective cleavage (associated with the formation of fragments of ODN I including probably the 3&#x2032;-phosphate end, since they comigrated as Maxam and Gilbert sequencing fragments) is observed in the close vicinity of the GG and AG sites (indicated as black bars in Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6</xref>, left). The intensity of the bands is much stronger at the GG site, reflecting the results of the primer extension experiments previously obtained. The four base pairs neighboring the GG site in the 5&#x2032;-direction are also affected by the cleavage of complex <bold>1</bold>. In the 3&#x2032;-direction, no clear bands are observed, but a smear is observed, which can be explained as follows: the cleavage products remain coordinated to the complex and have therefore a totally different mobility, compared with the Maxam&#x2013;Gilbert sequencing fragments. The apparent smear observed in the 3&#x2032;-direction supports this assumption, since such behavior is observed for Pt&#x2013;ODN I adducts including the copper complex (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>a, lane 6), and can therefore be expected for cleavage fragments that coordinate to the complex.</p>
        <p>A heating step in HEPES buffer (90&#xA0;&#xB0;C; pH 8.0) is often used to cleave the metastable products resulting from the oxidation of deoxyribose. This treatment of the cleavage products obtained with complexes <bold>1</bold>&#x2013;<bold>3</bold> did not show a strong increase of the DNA cuts (Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6</xref>, respective comparisons between lanes 15, 16 and 10 and 11, 20 and 22). Therefore, products of strand cleavage are essentially observed during this analysis. However, the smears observed in lanes 10 and 15 are partially converted into bands, indicating that some cleavage products, arising from the oxidation of deoxyribose, are sensitive to alkaline conditions.</p>
        <p>More drastic alkaline heating (as with piperidine) allows one to detect the oxidations of the nucleobases that do not induce direct DNA cleavage [<xref ref-type="bibr" rid="CR6">6</xref>]. Surprisingly when this treatment is applied to complexes <bold>1</bold> (with addition of 1&#xA0;equiv of copper) and <bold>2</bold>, clear cleavages are observed, although the systems had not been incubated with ascorbate (Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6</xref>, lanes 13 and 8, respectively). This phenomenon is dependent of the presence of copper ion, since it is not observed for Pt&#x2013;ODN I adducts with complex <bold>1</bold> without the addition of CuCl<sub>2</sub> (results not shown). Therefore, these alkaline conditions are sufficient to induce a redox activity of the copper complex part of the hybrid molecule [this phenomenon has not been observed with Cu(3-Clip-Phen), which can be removed during a precipitation step preceding the heating in the presence of piperidine]. Interestingly, only the Pt&#x2013;ODN I adducts are cleaved; none of the free ODN I is degraded and selective cleavages are observed around the position of adducts detected during primer extension experiments. Unfortunately, this activity of the copper complexes covalently linked to the target does not allow us to analyze whether or not the dual Pt&#x2013;Cu complexes perform the oxidation of nucleobases.</p>
      </sec>
      <sec id="Sec22">
        <title>Cleavage of the ODN II strand of the ODN I&#x2013;ODN II duplex</title>
        <p>The same experiments were performed with the ODNI&#x2013;ODNII duplex labeled on the 5&#x2032;-end of ODN II (Fig.&#xA0;<xref rid="Fig7" ref-type="fig">7</xref>). Similar amounts of Pt&#x2013;ODN II adducts are formed with complexes <bold>1</bold> (Fig.&#xA0;<xref rid="Fig7" ref-type="fig">7</xref>, lane 8) and <bold>2</bold> (Fig.&#xA0;<xref rid="Fig7" ref-type="fig">7</xref>, lane 3). Most likely, only parts of the platinum components of complexes <bold>1</bold> and <bold>2</bold> are bound on ODN II at the preferential AG site, and the cleavages do not seem to be restricted to one selective site. Other adducts are probably also present. The occurrence of platinum&#x2013;guanine monoadducts on ODN II (which is particularly rich in guanine bases) may explain the results observed. Further investigations are required to confirm these proposals.
<fig id="Fig7"><label>Fig.&#xA0;7</label><caption><p>PAGE analysis of cleavage of ODN II of the ODN I&#x2013;ODN II duplex (1&#xA0;&#x3BC;M) by compounds <bold>1</bold>&#x2013;<bold>3</bold>. The cleavage reactions were initiated with ascorbate (200&#xA0;&#x3BC;M) in aerobic conditions or by heating for 30&#xA0;min at 90&#xA0;&#xB0;C in aqueous 0.2&#xA0;M piperidine. The Maxam&#x2013;Gilbert sequencing reactions A&#xA0;+&#xA0;G (<italic>lane 1</italic>) and G (<italic>lane 2</italic>) were performed to determine the cleavage sites. On top of the gel are indicated the conditions used during the experiments (details are given in &#x201C;<xref rid="Sec2" ref-type="sec">Materials and methods</xref>&#x201D;). &#x394;pH 8 was a heating step of 30&#xA0;min at 90&#xA0;&#xB0;C in HEPES&#x2013;NaOH buffer (0.1&#xA0;M, pH 8.0). Unlinked complexes <bold>1</bold> and <bold>2</bold> were removed in a precipitation step with ethanol before the induction of cleavage</p></caption><graphic position="anchor" xlink:href="775_2008_346_Fig7_HTML" id="MO8"/></fig></p>
        <p>Both complex <bold>1</bold> with added copper and complex&#xA0;<bold>2</bold> show extensive cleavage activities in the presence of ascorbic acid in air (Fig.&#xA0;<xref rid="Fig7" ref-type="fig">7</xref>, lanes 11 and 6, respectively). In the experiments with complex <bold>2</bold>, the Pt&#x2013;ODN II adducts have fully reacted, while the free ODN II is only partly altered. The cleavage fragments are poorly resolved on the gel (a smear is essentially observed), and treatment with HEPES or piperidine fails to improve their analysis. These cleavage fragments are composed of modified DNA. It can be reasonably proposed that the fragments include Pt&#x2013;ODN II adducts and that these adducts produce a smear during the migration in polyacrylamide gel electrophoresis. All these results indicate that the platinum moieties of complexes <bold>1</bold> and <bold>2</bold> bind, as expected, to the preferential platinum site on ODN II, but also and mainly to single A and G nucleobases.</p>
      </sec>
      <sec id="Sec23">
        <title>Comparison between the cleavage of duplex and single-stranded DNA</title>
        <p>A comparison between the cleavage patterns resulting from the action of complex <bold>2</bold> on single-stranded ODN I and on the duplex ODN I&#x2013;ODN II was made to appraise the influence of the formation of Pt&#x2013;ODN II adducts on the resulting cleavage (Fig.&#xA0;<xref rid="Fig8" ref-type="fig">8</xref>). Pt&#x2013;ODN I adducts are formed when the single strand is used, and these adducts are essentially positioned at the GG site of ODN I (the results of the primer extension are not shown). For this study, only 20% of the platinum adducts on ODN I of the duplex and 40% of the platinum adducts on the single strand were created in order to have a maximum of one adduct per DNA target, and thus to simplify the analysis. The cleavage was induced by the addition of a small quantity of ascorbate (100&#xA0;&#x3BC;M) to disfavor recleavage events.
<fig id="Fig8"><label>Fig.&#xA0;8</label><caption><p>Phosphorimager scanning of the PAGE-cleavage patterns of ODN I by complex <bold>2</bold>. The cleavage was performed on either the ODN I&#x2013;ODN II duplex (5&#x2032;-end-labeled on ODN I) or on single-stranded ODN I. Cleavage was induced by the addition of ascorbate (100&#xA0;&#x3BC;M) after the removal of the unlinked complex during a precipitation step with ethanol. The clear band area on the 3&#x2032;-side of the GG site of the duplex is probably due to a covalent adduct of complex <bold>2</bold> on ODN II (the complementary strand of the duplex). 3&#x2032;-Phosphoglycolate cleavage fragments are labeled with an <italic>asterisk</italic>. The other clear bands were attributed to fragments of ODN I including 3&#x2032;-phosphate ends</p></caption><graphic position="anchor" xlink:href="775_2008_346_Fig8_HTML" id="MO9"/></fig></p>
        <p>The cleavage of the ODN I fragment of the duplex results in a cleavage pattern exhibiting various moderate peaks in the 3&#x2032;-region of the GG base pair of ODN I. The cleavage of single-stranded ODN I by complex <bold>2</bold> gives rise to a smear in the same region. The smears observed characterize cleaved ODN I products that are still coordinated to complex <bold>2</bold>. Accordingly, the weak peaks in this region of the DNA sequence are most likely due to the cleavage of complex <bold>2</bold>&#x2013;ODN II adducts on both strands. Since the conditions used favor a maximum of one Pt&#x2013;ODN adduct per duplex, these cleavages on nonmodified ODN I probably originate from complex <bold>2</bold>&#x2013;ODN II adducts.</p>
        <p>The results are summarized in Fig.&#xA0;<xref rid="Fig9" ref-type="fig">9</xref>. Importantly, the cleavage of ODN I by Pt&#x2013;ODN II adducts appears to be partially responsible of the visible nonselective cleavage of the duplex by complex <bold>2</bold>.
<fig id="Fig9"><label>Fig.&#xA0;9</label><caption><p>Summary of cleavage events due to platinum&#x2013;copper dual complex <bold>2</bold> on double-stranded DNA. The labeled strand of the DNA duplex that can be observed from denaturing PAGE experiment is labeled with an <italic>asterisk</italic></p></caption><graphic position="anchor" xlink:href="775_2008_346_Fig9_HTML" id="MO10"/></fig></p>
        <p>Interestingly, the weak peaks observed on the 5&#x2032;-side of the cleavage fragments (and shown with an asterisk in Fig.&#xA0;<xref rid="Fig8" ref-type="fig">8</xref>) probably correspond to DNA fragments with 3&#x2032;-phosphoglycolate extremities. Indeed, these species are observed at the position of the cleavage products of the duplex produced by the action of complex <bold>3</bold>, and which have been previously characterized [<xref ref-type="bibr" rid="CR15">15</xref>]. Such fragments were earlier identified as the result of the oxidation of the C4&#x2032; position of 2-deoxyribose. Further investigations are required to confirm these proposals.</p>
      </sec>
    </sec>
    <sec id="Sec24" sec-type="conclusion">
      <title>Concluding remarks</title>
      <p>The novel heterodinuclear platinum&#x2013;copper complex <bold>2</bold> exhibits improved nuclease activity, compared with its parent compound Cu(3-Clip-Phen) (<bold>3</bold>), and is able to perform double-strand breaks. The platinum moiety acts as an anchor to DNA, forcing the Cu(3-Clip-Phen) group to generate cuts in close proximity to the Pt&#x2013;DNA adducts, hence even allowing direct double-strand breaks. Mechanistic investigations on a 36-bp DNA fragment (ODN I&#x2013;ODN II) revealed that platinum adducts are indeed formed with both complexes <bold>1</bold> and <bold>2</bold>. The platinum moiety of complexes <bold>1</bold> and <bold>2</bold> binds to GG (primarily) and AG sites, like cisplatin. Nevertheless, the <italic>Taq</italic> polymerase enzyme stops at different base pairs for cisplatin and complexes <bold>1</bold> and <bold>2</bold>. This feature suggests that complexes <bold>1</bold> and <bold>2</bold> induce different distortions (compared with cisplatin) upon their binding to DNA, most likely owing to the bulkiness of the 3-Clip-Phen moiety. Complex <bold>1</bold> with added copper (1&#xA0;equiv) shows a sequence-selective cleavage, in the close proximity of the platinum adducts. A sequence-selective cleavage is also observed for complex <bold>2</bold>, but to a lesser extent compared with complex <bold>1</bold>. The opposite strand also contains Pt&#x2013;DNA adducts, but no clear sequence selectivity is observed, most likely owing to the lack of preferential platinum binding sites. These atypical platinum adducts lead to the partial damage of the other DNA strand, as is clearly evidenced by comparison of the cleavage products on a single-stranded or duplex DNA.</p>
      <p>Interestingly, it has been found that piperidine is also able to activate the Cu(3-Clip-Phen) component of the bifunctional platinum&#x2013;copper complexes, a feature so far not reported. Thus, a good sequence-selective cleavage is observed upon treatment of complex <bold>1</bold> with piperidine. Reasonable sequence selectivity is achieved with complex <bold>2</bold>. The investigation of the mechanism of cleavage by complex <bold>2</bold> is currently in progress.</p>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Electronic supplementary material</title>
      <supplementary-material id="N0x1cd98d0N0x2d2f480" content-type="local-data">
        <p>Below is the link to the electronic supplementary material.
</p>
        <media xlink:href="775_2008_346_MOESM1_ESM.pdf" id="MOESM1" mimetype="application" mime-subtype="pdf">
          <caption>
            <p>ESM1 (PDF 89.7 kb)</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack>
      <p>The authors are indebted to CERC3, CNRS France and the Chemical Research Council of the Netherlands, for financial support. The authors wish to thank Johnson &amp; Matthey (Reading, UK) for their generous loan of K<sub>2</sub>PtCl<sub>4</sub>. </p>
      <p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chabner</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Roberts</surname>
              <given-names>TG</given-names>
            </name>
          </person-group>
          <source>Nat Rev Cancer</source>
          <year>2005</year>
          <volume>5</volume>
          <fpage>65</fpage>
          <lpage>72</lpage>
          <pub-id pub-id-type="doi">10.1038/nrc1529</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Chabner BA, Roberts TG (2005) Nat Rev Cancer 5:65&#x2013;72 <pub-id pub-id-type="pmid">15630416</pub-id></citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hurley</surname>
              <given-names>LH</given-names>
            </name>
          </person-group>
          <source>Nat Rev Cancer</source>
          <year>2002</year>
          <volume>2</volume>
          <fpage>188</fpage>
          <lpage>200</lpage>
          <pub-id pub-id-type="doi">10.1038/nrc749</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Hurley LH (2002) Nat Rev Cancer 2:188&#x2013;200 <pub-id pub-id-type="pmid">11990855</pub-id></citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reedijk</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <source>Proc Natl Acad Sci USA</source>
          <year>2003</year>
          <volume>100</volume>
          <fpage>3611</fpage>
          <lpage>3616</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0737293100</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Reedijk J (2003) Proc Natl Acad Sci USA 100:3611&#x2013;3616 <pub-id pub-id-type="pmid">12655051</pub-id></citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Stubbe</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <source>Nat Rev Cancer</source>
          <year>2005</year>
          <volume>5</volume>
          <fpage>102</fpage>
          <lpage>112</lpage>
          <pub-id pub-id-type="doi">10.1038/nrc1547</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Chen JY, Stubbe J (2005) Nat Rev Cancer 5:102&#x2013;112 <pub-id pub-id-type="pmid">15685195</pub-id></citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Umezawa</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Maeda</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Takeuchi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Okami</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <source>J Antibiot</source>
          <year>1966</year>
          <volume>19</volume>
          <fpage>200</fpage>
          <lpage>209</lpage>
        </citation>
        <citation citation-type="display-unstructured">Umezawa H, Maeda K, Takeuchi T, Okami Y (1966) J Antibiot 19:200&#x2013;209 <pub-id pub-id-type="pmid">5953301</pub-id></citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burrows</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Muller</surname>
              <given-names>JG</given-names>
            </name>
          </person-group>
          <source>Chem Rev</source>
          <year>1998</year>
          <volume>98</volume>
          <fpage>1109</fpage>
          <lpage>1151</lpage>
          <pub-id pub-id-type="doi">10.1021/cr960421s</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Burrows CJ, Muller JG (1998) Chem Rev 98:1109&#x2013;1151 <pub-id pub-id-type="pmid">11848927</pub-id></citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Piti&#xE9;</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Boldron</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Pratviel</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <source>DNA oxidation by copper and manganese complexes</source>
          <year>2006</year>
          <publisher-loc>San Diego</publisher-loc>
          <publisher-name>Elsevier Academic Press</publisher-name>
        </citation>
        <citation citation-type="display-unstructured">Piti&#xE9; M, Boldron C, Pratviel G (2006) DNA oxidation by copper and manganese complexes. Elsevier Academic Press, San Diego </citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pratviel</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Bernadou</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Meunier</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <source>Angew Chem Int Ed Engl</source>
          <year>1995</year>
          <volume>34</volume>
          <fpage>746</fpage>
          <lpage>769</lpage>
          <pub-id pub-id-type="doi">10.1002/anie.199507461</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Pratviel G, Bernadou J, Meunier B (1995) Angew Chem Int Ed Engl 34:746&#x2013;769 </citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sigman</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Mazumder</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Perrin</surname>
              <given-names>DM</given-names>
            </name>
          </person-group>
          <source>Chem Rev</source>
          <year>1993</year>
          <volume>93</volume>
          <fpage>2295</fpage>
          <lpage>2316</lpage>
          <pub-id pub-id-type="doi">10.1021/cr00022a011</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Sigman DS, Mazumder A, Perrin DM (1993) Chem Rev 93:2295&#x2013;2316 </citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marshall</surname>
              <given-names>LE</given-names>
            </name>
            <name>
              <surname>Graham</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Reich</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Sigman</surname>
              <given-names>DS</given-names>
            </name>
          </person-group>
          <source>Biochemistry</source>
          <year>1981</year>
          <volume>20</volume>
          <fpage>244</fpage>
          <lpage>250</lpage>
          <pub-id pub-id-type="doi">10.1021/bi00505a003</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Marshall LE, Graham DR, Reich KA, Sigman DS (1981) Biochemistry 20:244&#x2013;250 <pub-id pub-id-type="pmid">7008837</pub-id></citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Veal</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Rill</surname>
              <given-names>RL</given-names>
            </name>
          </person-group>
          <source>Biochemistry</source>
          <year>1991</year>
          <volume>30</volume>
          <fpage>1132</fpage>
          <lpage>1140</lpage>
          <pub-id pub-id-type="doi">10.1021/bi00218a035</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Veal JM, Rill RL (1991) Biochemistry 30:1132&#x2013;1140 <pub-id pub-id-type="pmid">1989681</pub-id></citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zelenko</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Gallagher</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sigman</surname>
              <given-names>DS</given-names>
            </name>
          </person-group>
          <source>Angew Chem Int Ed Engl</source>
          <year>1997</year>
          <volume>36</volume>
          <fpage>2776</fpage>
          <lpage>2778</lpage>
          <pub-id pub-id-type="doi">10.1002/anie.199727761</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Zelenko O, Gallagher J, Sigman DS (1997) Angew Chem Int Ed Engl 36:2776&#x2013;2778 </citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goyne</surname>
              <given-names>TE</given-names>
            </name>
            <name>
              <surname>Sigman</surname>
              <given-names>DS</given-names>
            </name>
          </person-group>
          <source>J Am Chem Soc</source>
          <year>1987</year>
          <volume>109</volume>
          <fpage>2846</fpage>
          <lpage>2848</lpage>
          <pub-id pub-id-type="doi">10.1021/ja00243a060</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Goyne TE, Sigman DS (1987) J Am Chem Soc 109:2846&#x2013;2848 </citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kuwabara</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yoon</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Goyne</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Thederahn</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sigman</surname>
              <given-names>DS</given-names>
            </name>
          </person-group>
          <source>Biochemistry</source>
          <year>1986</year>
          <volume>25</volume>
          <fpage>7401</fpage>
          <lpage>7408</lpage>
          <pub-id pub-id-type="doi">10.1021/bi00371a023</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Kuwabara M, Yoon C, Goyne T, Thederahn T, Sigman DS (1986) Biochemistry 25:7401&#x2013;7408 <pub-id pub-id-type="pmid">3026454</pub-id></citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <citation citation-type="other">Piti&#xE9; M, Sudres B, Meunier B (1998) Chem Commun 2597&#x2013;2598</citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boldron</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ross</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Piti&#xE9;</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Meunier</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <source>Bioconjug Chem</source>
          <year>2002</year>
          <volume>13</volume>
          <fpage>1013</fpage>
          <lpage>1020</lpage>
          <pub-id pub-id-type="doi">10.1021/bc020013x</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Boldron C, Ross SA, Piti&#xE9; M, Meunier B (2002) Bioconjug Chem 13:1013&#x2013;1020 <pub-id pub-id-type="pmid">12236783</pub-id></citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Piti&#xE9;</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Horn</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Brion</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Burrows</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Meunier</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <source>Bioconjug Chem</source>
          <year>2000</year>
          <volume>11</volume>
          <fpage>892</fpage>
          <lpage>900</lpage>
          <pub-id pub-id-type="doi">10.1021/bc000050t</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Piti&#xE9; M, Van Horn JD, Brion D, Burrows CJ, Meunier B (2000) Bioconjug Chem 11:892&#x2013;900 <pub-id pub-id-type="pmid">11087339</pub-id></citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Piti&#xE9;</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Burrows</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Meunier</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <source>Nucleic Acids Res</source>
          <year>2000</year>
          <volume>28</volume>
          <fpage>4856</fpage>
          <lpage>4864</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/28.24.4856</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Piti&#xE9; M, Burrows CJ, Meunier B (2000) Nucleic Acids Res 28:4856&#x2013;4864 <pub-id pub-id-type="pmid">11121476</pub-id></citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hoog</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Boldron</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Gamez</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Sliedregt-Bol</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Roland</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Piti&#xE9;</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <source>J Med Chem</source>
          <year>2007</year>
          <volume>50</volume>
          <fpage>3148</fpage>
          <lpage>3152</lpage>
          <pub-id pub-id-type="doi">10.1021/jm0614331</pub-id>
        </citation>
        <citation citation-type="display-unstructured">de Hoog P, Boldron C, Gamez P, Sliedregt-Bol K, Roland I, Piti&#xE9; M et al (2007) J Med Chem 50:3148&#x2013;3152 <pub-id pub-id-type="pmid">17521178</pub-id></citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rosenberg</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Camp</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Trosko</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Mansour</surname>
              <given-names>VH</given-names>
            </name>
          </person-group>
          <source>Nature</source>
          <year>1969</year>
          <volume>222</volume>
          <fpage>385</fpage>
          <lpage>386</lpage>
          <pub-id pub-id-type="doi">10.1038/222385a0</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Rosenberg B, van Camp L, Trosko JE, Mansour VH (1969) Nature 222:385&#x2013;386 <pub-id pub-id-type="pmid">5782119</pub-id></citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jamieson</surname>
              <given-names>ER</given-names>
            </name>
            <name>
              <surname>Lippard</surname>
              <given-names>SJ</given-names>
            </name>
          </person-group>
          <source>Chem Rev</source>
          <year>1999</year>
          <volume>99</volume>
          <fpage>2467</fpage>
          <lpage>2498</lpage>
          <pub-id pub-id-type="doi">10.1021/cr980421n</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Jamieson ER, Lippard SJ (1999) Chem Rev 99:2467&#x2013;2498 <pub-id pub-id-type="pmid">11749487</pub-id></citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kostrhunova</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Brabec</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <source>Biochemistry</source>
          <year>2000</year>
          <volume>39</volume>
          <fpage>12639</fpage>
          <lpage>12649</lpage>
          <pub-id pub-id-type="doi">10.1021/bi000710h</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Kostrhunova H, Brabec V (2000) Biochemistry 39:12639&#x2013;12649 <pub-id pub-id-type="pmid">11027144</pub-id></citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Robillard</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Davies</surname>
              <given-names>NP</given-names>
            </name>
            <name>
              <surname>Marel</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Boom</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Reedijk</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Murray</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <source>J Inorg Biochem</source>
          <year>2003</year>
          <volume>96</volume>
          <fpage>331</fpage>
          <lpage>338</lpage>
          <pub-id pub-id-type="doi">10.1016/S0162-0134(03)00180-6</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Robillard MS, Davies NP, van der Marel GA, van Boom JH, Reedijk J, Murray V (2003) J Inorg Biochem 96:331&#x2013;338 <pub-id pub-id-type="pmid">12888268</pub-id></citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Temple</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>McFadyen</surname>
              <given-names>WD</given-names>
            </name>
            <name>
              <surname>Holmes</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Denny</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>Murray</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <source>Biochemistry</source>
          <year>2000</year>
          <volume>39</volume>
          <fpage>5593</fpage>
          <lpage>5599</lpage>
          <pub-id pub-id-type="doi">10.1021/bi9922143</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Temple MD, McFadyen WD, Holmes RJ, Denny WA, Murray V (2000) Biochemistry 39:5593&#x2013;5599 <pub-id pub-id-type="pmid">10820033</pub-id></citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Fasman</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <source>Handbook of biochemistry and molecular biology: nucleic acids</source>
          <year>1975</year>
          <publisher-loc>Boca Raton</publisher-loc>
          <publisher-name>CRC Press</publisher-name>
          <fpage>175</fpage>
        </citation>
        <citation citation-type="display-unstructured">Fasman G (1975) Handbook of biochemistry and molecular biology: nucleic acids. CRC Press, Boca Raton, p 175 </citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Sambrook</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Fritsch</surname>
              <given-names>EF</given-names>
            </name>
            <name>
              <surname>Maniatis</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <source>Molecular cloning: a laboratory manual</source>
          <year>1989</year>
          <publisher-loc>Cold Spring Harbor</publisher-loc>
          <publisher-name>Cold Spring Harbor Laboratory Press</publisher-name>
        </citation>
        <citation citation-type="display-unstructured">Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor </citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maxam</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Gilbert</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <source>Proc Natl Acad Sci USA</source>
          <year>1977</year>
          <volume>74</volume>
          <fpage>560</fpage>
          <lpage>564</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.74.2.560</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Maxam AM, Gilbert W (1977) Proc Natl Acad Sci USA 74:560&#x2013;564 <pub-id pub-id-type="pmid">265521</pub-id></citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haber</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
          <source>Trends Genet</source>
          <year>2000</year>
          <volume>16</volume>
          <fpage>259</fpage>
          <lpage>264</lpage>
          <pub-id pub-id-type="doi">10.1016/S0168-9525(00)02022-9</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Haber JE (2000) Trends Genet 16:259&#x2013;264 <pub-id pub-id-type="pmid">10827453</pub-id></citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Karran</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <source>Curr Opin Genet Dev</source>
          <year>2000</year>
          <volume>10</volume>
          <fpage>144</fpage>
          <lpage>150</lpage>
          <pub-id pub-id-type="doi">10.1016/S0959-437X(00)00069-1</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Karran P (2000) Curr Opin Genet Dev 10:144&#x2013;150 <pub-id pub-id-type="pmid">10753787</pub-id></citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ackley</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Barry</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>Mounce</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Farmer</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Springer</surname>
              <given-names>BE</given-names>
            </name>
            <name>
              <surname>Day</surname>
              <given-names>CS</given-names>
            </name>
            <etal/>
          </person-group>
          <source>J Biol Inorg Chem</source>
          <year>2004</year>
          <volume>9</volume>
          <fpage>453</fpage>
          <lpage>461</lpage>
          <pub-id pub-id-type="doi">10.1007/s00775-004-0541-4</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Ackley MC, Barry CG, Mounce AM, Farmer MC, Springer BE, Day CS et al (2004) J Biol Inorg Chem 9:453&#x2013;461 <pub-id pub-id-type="pmid">15067524</pub-id></citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bassett</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Vaisman</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Havener</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Masutani</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hanaoka</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Chaney</surname>
              <given-names>SG</given-names>
            </name>
          </person-group>
          <source>Biochemistry</source>
          <year>2003</year>
          <volume>42</volume>
          <fpage>14197</fpage>
          <lpage>14206</lpage>
          <pub-id pub-id-type="doi">10.1021/bi035359p</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Bassett E, Vaisman A, Havener JM, Masutani C, Hanaoka F, Chaney SG (2003) Biochemistry 42:14197&#x2013;14206 <pub-id pub-id-type="pmid">14640687</pub-id></citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Galea</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Murray</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <source>Biochim Biophys Acta Gene Struct Expr</source>
          <year>2002</year>
          <volume>1579</volume>
          <fpage>142</fpage>
          <lpage>152</lpage>
        </citation>
        <citation citation-type="display-unstructured">Galea AM, Murray V (2002) Biochim Biophys Acta Gene Struct Expr 1579:142&#x2013;152 </citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kasparkova</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Novakova</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Farrell</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Brabec</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <source>Biochemistry</source>
          <year>2003</year>
          <volume>42</volume>
          <fpage>792</fpage>
          <lpage>800</lpage>
          <pub-id pub-id-type="doi">10.1021/bi026614t</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Kasparkova J, Novakova O, Farrell N, Brabec V (2003) Biochemistry 42:792&#x2013;800 <pub-id pub-id-type="pmid">12534292</pub-id></citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Murray</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Motyka</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>England</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Wickham</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>HH</given-names>
            </name>
            <name>
              <surname>Denny</surname>
              <given-names>WA</given-names>
            </name>
            <etal/>
          </person-group>
          <source>Biochemistry</source>
          <year>1992</year>
          <volume>31</volume>
          <fpage>11812</fpage>
          <lpage>11817</lpage>
          <pub-id pub-id-type="doi">10.1021/bi00162a020</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Murray V, Motyka H, England PR, Wickham G, Lee HH, Denny WA et al (1992) Biochemistry 31:11812&#x2013;11817 <pub-id pub-id-type="pmid">1445914</pub-id></citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Murray</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Motyka</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>England</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Wickham</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>HH</given-names>
            </name>
            <name>
              <surname>Denny</surname>
              <given-names>WA</given-names>
            </name>
            <etal/>
          </person-group>
          <source>J Biol Chem</source>
          <year>1992</year>
          <volume>267</volume>
          <fpage>18805</fpage>
          <lpage>18809</lpage>
        </citation>
        <citation citation-type="display-unstructured">Murray V, Motyka H, England PR, Wickham G, Lee HH, Denny WA et al (1992) J Biol Chem 267:18805&#x2013;18809 <pub-id pub-id-type="pmid">1527009</pub-id></citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Temple</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Recabarren</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>McFadyen</surname>
              <given-names>WD</given-names>
            </name>
            <name>
              <surname>Holmes</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Denny</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>Murray</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <source>Biochim Biophys Acta Gene Struct Expr</source>
          <year>2002</year>
          <volume>1574</volume>
          <fpage>223</fpage>
          <lpage>230</lpage>
        </citation>
        <citation citation-type="display-unstructured">Temple MD, Recabarren P, McFadyen WD, Holmes RJ, Denny WA, Murray V (2002) Biochim Biophys Acta Gene Struct Expr 1574:223&#x2013;230 </citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vaisman</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Chaney</surname>
              <given-names>SG</given-names>
            </name>
          </person-group>
          <source>J Biol Chem</source>
          <year>2000</year>
          <volume>275</volume>
          <fpage>13017</fpage>
          <lpage>13025</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.275.17.13017</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Vaisman A, Chaney SG (2000) J Biol Chem 275:13017&#x2013;13025 <pub-id pub-id-type="pmid">10777605</pub-id></citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Woynarowski</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Chapman</surname>
              <given-names>WG</given-names>
            </name>
            <name>
              <surname>Napier</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Herzig</surname>
              <given-names>MCS</given-names>
            </name>
            <name>
              <surname>Juniewicz</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <source>Mol Pharmacol</source>
          <year>1998</year>
          <volume>54</volume>
          <fpage>770</fpage>
          <lpage>777</lpage>
        </citation>
        <citation citation-type="display-unstructured">Woynarowski JM, Chapman WG, Napier C, Herzig MCS, Juniewicz P (1998) Mol Pharmacol 54:770&#x2013;777 <pub-id pub-id-type="pmid">9804612</pub-id></citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zou</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Vanhouten</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Farrell</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <source>Biochemistry</source>
          <year>1994</year>
          <volume>33</volume>
          <fpage>5404</fpage>
          <lpage>5410</lpage>
          <pub-id pub-id-type="doi">10.1021/bi00184a007</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Zou Y, Vanhouten B, Farrell N (1994) Biochemistry 33:5404&#x2013;5410 <pub-id pub-id-type="pmid">8180163</pub-id></citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Petitjean</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Barton</surname>
              <given-names>JK</given-names>
            </name>
          </person-group>
          <source>J Am Chem Soc</source>
          <year>2004</year>
          <volume>126</volume>
          <fpage>14728</fpage>
          <lpage>14729</lpage>
          <pub-id pub-id-type="doi">10.1021/ja047235l</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Petitjean A, Barton JK (2004) J Am Chem Soc 126:14728&#x2013;14729 <pub-id pub-id-type="pmid">15535691</pub-id></citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <citation citation-type="other">Thurston DE, Morris SJ, Hartley JA (1996) Chem Commun 563&#x2013;565</citation>
      </ref>
    </ref-list>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>3-Clip-Phen</term>
          <def>
            <p>1-(1,10-Phenanthrolin-3-yloxy)-3-(1,10-phenanthrolin-8-yloxy)propan-2-amine</p>
          </def>
        </def-item>
        <def-item>
          <term>DCM</term>
          <def>
            <p>Dichloromethane</p>
          </def>
        </def-item>
        <def-item>
          <term>DMF</term>
          <def>
            <p>Dimethylformamide</p>
          </def>
        </def-item>
        <def-item>
          <term>DMSO</term>
          <def>
            <p>Dimethyl sulfoxide</p>
          </def>
        </def-item>
        <def-item>
          <term>ESI</term>
          <def>
            <p>Electrospray ionization</p>
          </def>
        </def-item>
        <def-item>
          <term>HEPES</term>
          <def>
            <p>4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid</p>
          </def>
        </def-item>
        <def-item>
          <term>MS</term>
          <def>
            <p>Mass spectrometry</p>
          </def>
        </def-item>
        <def-item>
          <term>ODN</term>
          <def>
            <p>Oligonucleotide</p>
          </def>
        </def-item>
        <def-item>
          <term>TBE</term>
          <def>
            <p>2-Amino-2-(hydroxymethyl)propane-1,3-diol borate edta</p>
          </def>
        </def-item>
        <def-item>
          <term>Tris</term>
          <def>
            <p>2-Amino-2-(hydroxymethyl)propane-1,3-diol</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <fn-group>
      <fn>
        <p>
          <bold>Electronic supplementary material</bold>
        </p>
        <p>The online version of this article (doi:10.1007/s00775-008-0346-y) contains supplementary material, which is available to authorized users.</p>
      </fn>
    </fn-group>
  </back>
</article>
</pmc-articleset>